Stage IIIB Skin Melanoma Completed Phase 1 Trials for RG-4733 (DB11870)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029534 (Stage IIIB Skin Melanoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | Treatment |